Spiderwort

Spiderwort is a developer of plant-based biomaterials for repair and regeneration of tissues. The company has developed an open-source platform that uses plant-derived cellulose to create scaffold architectures of organs. Products include CelluBridge, a proprietary plant-based biomaterial that promotes the repair and regeneration of the spinal cord, and CelluJuve, a plant-based dermal filler that can assist with injury recovery and cosmetic enhancement. Spiderwort leverages cellulose-based biomaterials to create biocompatible scaffolds that support tissue growth and healing, offering sustainable alternatives to synthetic and animal-derived biomaterials. Founded in 2017 and headquartered in Ottawa, Canada, Spiderwort has raised approximately 16.1 million at the Series A stage with investors including Horizons Ventures, K5 Global, Anges Quebec, BoxOne Ventures, Ontario Brain Institute, and Flucas Ventures.